The Basic Principles Of ABBV-744
In this article we clearly show that DNL343 minimizes ISR activation and neurodegeneration introduced on acutely by an optic nerve crush (ONC) injuries or chronically by a germline eIF2B LOF mutation in mice. We also exhibit that DNL343 therapy, initiated in a late phase of ailment which much more correctly replicates a scientific dosing paradigm,